Insomnia? How better sleep may help cancer patients
Contact: Elizabeth Allen, 210-450-2020
SAN ANTONIO (June 12, 2012) – Everyone needs a good night’s sleep, but cancer patients often have extra hurdles between them and healing slumber, while their need for it is even more vital.
Three experts will address these issues at a free public lecture on Thursday, June 14. The lecture, to be held at the Cancer Therapy & Research Center of The University of Texas Health Science Center at San Antonio, will cover sleep problems, ways to deal with them and the importance of sleep to overall good health.
Angela Velez, M.D., assistant professor of neurology in the School of Medicine, will talk about insomnia and available treatments, as well as periodic leg movements and sleep apnea, as those disorders are common in cancer patients.
Amy Arisco, M.D., assistant professor of urology, will focus on nocturia, or frequent nighttime urination, and will offer tips on managing it.
Wendy Crabbe, RN, M.S.N., an adult nurse practitioner specializing in oncology, will address fatigue, psychosocial issues and pain management as they relate to sleep problems.
The lecture, which is open to the public and has a question-and-answer session, will be from 6 to 7:30 p.m. on the fourth floor of the CTRC’s Grossman Building, 7979 Wurzbach Rd., San Antonio.
For more information call 210-450-1152. It will be streamed live online at www.CTRC.net/LIVE.
The lecture is also sponsored by H-E-B and the Institute for the Integration of Medicine and Science at the UT Health Science Center San Antonio.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI)-designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.
HOME [HSC NEWS]
| About UTHSCSA
| News Releases | Mission
Magazine | Grand Rounds Newly
Granted | Submit News | HSC
News Archive | Video Index